When is a patient with bacterial vaginosis (BV) no longer contagious after completing a 5 to 7 day course of Flagyl (metronidazole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When Are You No Longer Contagious with Bacterial Vaginosis After Taking Flagyl?

Bacterial vaginosis is not considered a contagious or sexually transmitted infection, so the concept of being "contagious" does not apply to BV in the traditional sense. 1

Why BV Is Not Treated as a Contagious Condition

  • Male sex partners of women with BV are not symptomatic, and the CDC explicitly states that preventing transmission to men is not a goal of therapy. 1

  • Treatment of male partners has been shown in clinical trials to have no effect on either the clinical course of BV in women during treatment or the relapse/reinfection rate. 1 Therefore, routine treatment of sex partners is not recommended. 2, 3

  • The primary goal of treating BV with metronidazole is to relieve vaginal symptoms and signs of infection in the affected woman, not to prevent transmission. 1

When Treatment Is Complete and Symptoms Resolve

  • After completing a standard 7-day course of oral metronidazole 500 mg twice daily, follow-up visits are not necessary if symptoms resolve. 1, 2

  • The CDC reports cure rates of 95% for the 7-day metronidazole regimen, with relief of symptoms and improvement in clinical course and vaginal flora disturbances. 1

  • No specific "contagious period" exists because BV represents an imbalance of normal vaginal flora rather than transmission of a pathogen. 1

Important Clinical Context

  • BV is characterized by an overgrowth of polymicrobial bacteria that normally exist in the vagina, not by acquisition of a new infectious agent from a partner. 4

  • Recurrence of BV is common (approaching 50% within 12 months), but this represents relapse or recolonization with the woman's own flora rather than reinfection from a partner. 2, 4, 5

  • Sexual activity may influence BV recurrence through changes in vaginal pH and flora, but abstinence or protected sex during and after treatment is associated with better cure rates—not because of preventing "contagion" but because of maintaining vaginal flora balance. 5

Common Pitfall to Avoid

  • Do not counsel patients that they need to wait a specific period after treatment to avoid "spreading" BV to partners, as this misrepresents the nature of the condition. 1 The focus should be on symptom resolution and maintaining vaginal health rather than infectivity concerns.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bacterial Vaginosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Bacterial Vaginosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.